Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Total Debt (2019 - 2023)

Alx Oncology Holdings' Total Debt history spans 5 years, with the latest figure at $9.6 million for Q3 2023.

  • For Q3 2023, Total Debt rose 82.07% year-over-year to $9.6 million; the TTM value through Sep 2023 reached $9.6 million, up 82.07%, while the annual FY2022 figure was $11.0 million, 264.32% up from the prior year.
  • Total Debt for Q3 2023 was $9.6 million at Alx Oncology Holdings, up from $9.5 million in the prior quarter.
  • Across five years, Total Debt topped out at $11.0 million in Q4 2022 and bottomed at $3.0 million in Q4 2021.
  • The 5-year median for Total Debt is $5.7 million (2020), against an average of $7.1 million.
  • The largest annual shift saw Total Debt skyrocketed 264.32% in 2022 before it surged 82.07% in 2023.
  • A 5-year view of Total Debt shows it stood at $5.4 million in 2019, then rose by 6.25% to $5.8 million in 2020, then tumbled by 47.4% to $3.0 million in 2021, then surged by 264.32% to $11.0 million in 2022, then fell by 13.26% to $9.6 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Total Debt are $9.6 million (Q3 2023), $9.5 million (Q2 2023), and $10.3 million (Q1 2023).